Dr. Rikin Sanjay Kadakia, MD

Dr. Kadakia practices at Salinas Valley Health Clinics in Salinas, California.

Dr. Kadakia's NPI, 1154718526, was assigned on April 23, 2015. Dr. Kadakia graduated from American University of the Caribbean School of Medicine in 2015. Dr. Kadakia holds California license A170650.

Dr. Kadakia's primary practice is Salinas Valley Health Clinics, at 355 Abbott St, Salinas, CA 93901 in Monterey County. The practice phone is (831) 755-1701.

Dr. Kadakia's primary practice is Salinas Valley Health Clinics in Salinas, California. Dr. Kadakia is also affiliated with Salinas Valley Health Medical Center. The medical group on file is Salinas Valley Health Clinics. Dmand AI also links Dr. Kadakia to 4 more hospitals, 3 group practices and clinics, 3 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadakia practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kadakia's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kadakia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kadakia's licenses on file in 4 states: California, Florida, Louisiana and Virginia.

Dmand AI lists angioplasty, cardiac catheterization and pacemaker or defibrillator implantation among the conditions Dr. Kadakia treats.

CMS data shows 3,719 Medicare services from Dr. Kadakia across 40 procedure codes in 2024, for 1,190 Medicare patients. Medicare paid $269,643 for them.

CMS counts 1,190 Medicare patients who saw Dr. Kadakia in 2024. The largest group is 65 to 74, with 478 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.91, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kadakia's median patient age at 60, with 54% women.

In 2024, Dr. Kadakia wrote 1,739 Medicare Part D claims for 303 patients. 86% of them were for generic drugs. CMS names the drug for 1,567 of them, across 30 drugs with 11 or more claims each, at $217,090 in total drug cost. In 2023, CMS named 90 claims across 2 drugs.

Dr. Kadakia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 66 procedures of coronary angioplasty and stenting by Dr. Kadakia, more than 90% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Kadakia, published from 2019 to 2022. 2019 was the busiest year, with 2. Dr. Kadakia's most frequent co-authors are Paari Dominic, MBBS, Sergey Kachur, MD and Selim Ramzi Krim, MD.

CMS Open Payments shows 667 general payments to Dr. Kadakia from 51 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Novo Nordisk Inc paid the most, $137,856.

Dr. Kadakia graduated from American University of the Caribbean School of Medicine in 2015.

Dr. Kadakia is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.